Terazosin hydrochloride

Cat. No.: PI63074088

Description: Terazosin hydrochloride belongs to the group of prazosin derivatives. The active substance inhibits non-selectively α-adrenoreceptors and therefore induces vasodilation and hypotension. It is used for the treatment of benign prostate enlargements and essential hypertension.

Product Details

CAS	63074-08-8
Molecular Formula	C13H25N5O6·2H2O·HCl
Molecular Weight	459.92
Product Status	Commercial
Uses	Urologicals
Molecular Size	Small
Controlled Substance	No

* Our products are for research use only.

Get in Touch

We’re glad to help you with your products and services demands. For any inquiry, question or recommendation, please send an email to or fill out the following form.

Name *

Phone

Email *

Address *

Products & Service of Interest *

Project Description

Verification Code *